- CasNo 57103-68-1
- Purity 99%
Location:Home > Pharmaceutical
Chemical plants supply high-quality Maytansine, O3-de2-(acetylmethylamino)-1-oxopropyl- 57103-68-1 in bulk
- Molecular Formula: C28H37 Cl N2 O8
- Molecular Weight: 565.063
- Vapor Pressure: 1.24E-29mmHg at 25°C
- Melting Point: 205-207℃
- Boiling Point: 835.8°Cat760mmHg
- PKA: 9.89±0.70(Predicted)
- Flash Point: 459.3°C
- PSA: 130.09000
- Density: 1.34g/cm3
- LogP: 3.51050
Maytansine, O3-de2-(acetylmethylamino)-1-oxopropyl-(Cas 57103-68-1) Usage
|
Biological Activity |
Maytansinol is an ansamacrolide originally isolated from P. verrucose that has antimitotic and anticancer activities. It inhibits polymerization and induces depolymerization of bovine brain tubulin with EC50 values of 12 and 43 μM, respectively. Maytansinol inhibits sea urchin egg mitosis when used at a concentration of 10 μM and decreases proliferation of KB nasopharyngeal cancer cells (EC50 = 0.19 μg/ml). |
|
Mode of action |
Maytansinol (1 b) was first obtained by Kupchan et?al. both by isolation from Putterlickia verrucose and chemical removal of the acyl group from the hydroxy group at the C3 position. It showed weaker inhibitory activity on tubulin polymerization than maytansine, thus implying that the ester moiety at the C3 position of ansamitocins, maytansine, and maytansinoids plays an important role for biological activity and cell permeability. In fact, it has just recently been found that the carbonyl oxygen atom of the ester moiety forms a strong intramolecular interaction with the hydroxy group at position 9, fixing the bioactive conformation. Maytansinol has been regarded as a valuable precursor because acylation allows the preparation of both natural and new semisynthetic maytansinoids, differing in the ester side-chain substituents (Scheme 1). The acylation reaction of maytansinol is a crucial step in the preparation of maytansinoid ADCs or nanoparticles, constituting an uprising class of targeted cancer therapeutics. A few attempts to conjugate maytansinoids to peptides by this reaction have also been made very recently. Furthermore, considering that the maytansine binding site is one of the most recently identified and least explored on tubulin, acylation of maytansinol may serve for the preparation of useful molecular probes to better understand the structure-activity relationships of maytansinoids or to identify new maytansine-site ligands.Structure of maytansine (1 a), maytansinol (1 b), and the generic acylation reaction of maytansinol. |
InChI:InChI=1/C28H37ClN2O8/c1-15-8-7-9-22(37-6)28(35)14-20(38-26(34)30-28)16(2)25-27(3,39-25)21(32)13-23(33)31(4)18-11-17(10-15)12-19(36-5)24(18)29/h7-9,11-12,16,20-22,25,32,35H,10,13-14H2,1-6H3,(H,30,34)/b9-7+,15-8-
57103-68-1 Relevant articles
Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoids.
Kupchan,Sneden,Branfman,Howie,Rebhun,McIvor,Wang,Schnaitman
, p. 31 - 37 (1978)
In an effort to determine the structural...
-
Asai,M. et al.
, p. 1079 - 1085 (1979)
-
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinoma
Porter, John,Ding, Yao,Hale, Sarah J.M.,Perrins, Richard D.,Robinson, Angela,Mazanetz, Michael P.,Wu, Yubo,Ma, Yinping,Conlon, Kelly,Coulter, Tom
, (2020)
Gold nanoparticles are promising drug de...
Maytansine dechloridation compound, intermediate, preparation method of compound and application
-
Paragraph 0074-0077, (2020/12/09)
The invention discloses a maytansine dec...
Uses of immunoconjugates targeting CD138
-
Page/Page column 12, (2018/11/23)
Disclosed is a method and composition fo...
Uses of immunoconjugates targeting CD138
-
Sheet 2, (2016/04/20)
Disclosed are methods and treatment regi...
57103-68-1 Process route
-
-
66584-72-3,93221-27-3
ansamitocin P-3
-
-
57103-68-1
maytansinol
| Conditions | Yield |
|---|---|
|
With
lithium aluminium tetrahydride;
In
tetrahydrofuran;
at -20 ℃;
for 2h;
|
|
|
With
lithium (hydro)trimethoxyaluminate;
|
|
|
With
lithium (hydro)trimethoxyaluminate;
|
|
|
With
lithium (hydro)trimethoxyaluminate;
In
tetrahydrofuran;
at -40 ℃;
|
|
|
With
lithium (hydro)trimethoxyaluminate;
In
tetrahydrofuran;
at -40 ℃;
for 1.5h;
Inert atmosphere;
|
-
-
38997-10-3,70774-06-0
maytanbutine
-
-
57103-68-1
maytansinol
| Conditions | Yield |
|---|---|
|
With
lithium aluminium tetrahydride;
In
tetrahydrofuran;
at -23 ℃;
for 3h;
|
57103-68-1 Upstream products
-
66584-72-3
ansamitocin P-3
-
66584-72-3
ansamitocin P-3
-
38997-10-3
maytanbutine
-
75340-68-0
(-)-maytansinol
57103-68-1 Downstream products
-
57103-69-2
maytanacine
-
57103-70-5
C-15003 P-2,Maytanacinolpropionat
-
796073-68-2
N2' -deacetyl-N2' -[4-methyl-4-(methyldithio)-1-oxopentyl]maytansine
-
902768-55-2
N2' -deacetyl-N2' -[4-methyl-4-(methyldithio)-1-oxopentyl]-D-maytansine
WANT TO PURCHASE
Please contact us and we will reply to you as soon as possible.